116 related articles for article (PubMed ID: 9888357)
1. Species specificity of monoclonal antibodies to human tartrate-resistant acid phosphatase.
Janckila AJ; Walton SP; Yam LT
Biotech Histochem; 1998 Nov; 73(6):316-24. PubMed ID: 9888357
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibodies specific to human tartrate-resistant acid phosphatase.
Janckila AJ; Cardwell EM; Yam LT
Hybridoma; 1997 Apr; 16(2):175-82. PubMed ID: 9145320
[TBL] [Abstract][Full Text] [Related]
3. Characterization of four monoclonal antibodies to recombinant human tartrate-resistant acid phosphatase.
Miyazaki T; Matsunaga T; Miyazaki S; Hokari S; Komoda T
Hybrid Hybridomics; 2002 Jun; 21(3):191-5. PubMed ID: 12165145
[TBL] [Abstract][Full Text] [Related]
4. Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Janckila AJ; Cardwell EM; Yam LT; Li CY
Blood; 1995 May; 85(10):2839-44. PubMed ID: 7742545
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Hoyer JD; Li CY; Yam LT; Hanson CA; Kurtin PJ
Am J Clin Pathol; 1997 Sep; 108(3):308-15. PubMed ID: 9291460
[TBL] [Abstract][Full Text] [Related]
6. The value of tartrate resistant acid phosphatase (TRAP) immunoreactivity in diagnosis of hairy cell leukemia.
Akkaya H; Dogan O; Agan M; Dincol G
APMIS; 2005 Mar; 113(3):162-6. PubMed ID: 15799758
[TBL] [Abstract][Full Text] [Related]
7. Epitope enhancement for immunohistochemical demonstration of tartrate-resistant acid phosphatase.
Janckila AJ; Lear SC; Martin AW; Yam LT
J Histochem Cytochem; 1996 Mar; 44(3):235-44. PubMed ID: 8648083
[TBL] [Abstract][Full Text] [Related]
8. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.
Halleen JM; Karp M; Viloma S; Laaksonen P; Hellman J; Käkönen SM; Stepan JJ; Holmes S; Väänänen Hk; Pettersson K
J Bone Miner Res; 1999 Mar; 14(3):464-9. PubMed ID: 10027912
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues.
Yaziji H; Janckila AJ; Lear SC; Martin AW; Yam LT
Am J Clin Pathol; 1995 Oct; 104(4):397-402. PubMed ID: 7572788
[TBL] [Abstract][Full Text] [Related]
10. Anti-TRAP 14G6 is effective for immunochemistry.
Janckila AJ; Yam LT
Hybridoma; 1998 Oct; 17(5):487. PubMed ID: 9873995
[No Abstract] [Full Text] [Related]
11. Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase.
Nakasato YR; Janckila AJ; Halleen JM; Vaananen HK; Walton SP; Yam LT
Clin Chem; 1999 Dec; 45(12):2150-7. PubMed ID: 10585347
[TBL] [Abstract][Full Text] [Related]
12. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay.
Halleen JM; Hentunen TA; Karp M; Käkönen SM; Pettersson K; Väänänen HK
J Bone Miner Res; 1998 Apr; 13(4):683-7. PubMed ID: 9556068
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of putative monoclonal and polyclonal antibodies against tartrate-resistant acid phosphatase.
Nelson PN; Chambers T
Hybridoma; 1995 Feb; 14(1):91-4. PubMed ID: 7768539
[TBL] [Abstract][Full Text] [Related]
14. Tartrate-resistant acid phosphatase from human bone: purification and development of an immunoassay.
Halleen J; Hentunen TA; Hellman J; Väänänen HK
J Bone Miner Res; 1996 Oct; 11(10):1444-52. PubMed ID: 8889844
[TBL] [Abstract][Full Text] [Related]
15. Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium.
Alatalo SL; Halleen JM; Hentunen TA; Mönkkönen J; Väänänen HK
Clin Chem; 2000 Nov; 46(11):1751-4. PubMed ID: 11067809
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: development of a specific immunoassay of the isoenzyme in serum.
Chamberlain P; Compston J; Cox TM; Hayman AR; Imrie RC; Reynolds K; Holmes SD
Clin Chem; 1995 Oct; 41(10):1495-9. PubMed ID: 7586523
[TBL] [Abstract][Full Text] [Related]
18. Applications and performance of monoclonal antibodies to human tartrate resistant acid phosphatase.
Pradella SD; Slone SP; Wu YY; Chao TY; Parthasarathy RN; Yam LT; Janckila AJ
J Immunol Methods; 2011 Sep; 372(1-2):162-70. PubMed ID: 21787778
[TBL] [Abstract][Full Text] [Related]
19. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy.
Hayman AR
Autoimmunity; 2008 Apr; 41(3):218-23. PubMed ID: 18365835
[TBL] [Abstract][Full Text] [Related]
20. Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Kraenzlin ME; Lau KH; Liang L; Freeman TK; Singer FR; Stepan J; Baylink DJ
J Clin Endocrinol Metab; 1990 Aug; 71(2):442-51. PubMed ID: 2380339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
